Jong Chul Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jong Chul Chung has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Dong Yoo
Department of Neurosurgery, Eulji University Hospital, Eulji University College of Medicine, Republic of Korea
1 shared publication - Ki Seok Park
Department of Neurosurgery and Neurology, Eulji University Hospital, College of Medicine, Eulji University, Daejeon 35233, Republic of Korea
1 shared publication - Moon Sun Park
Department of Neurosurgery, Eulji University Hospital, Eulji University College of Medicine, Daejeon 35233, Republic of Korea
1 shared publication - Seong Min Kim
Department of Neurosurgery and Neurology, Eulji University Hospital, College of Medicine, Eulji University, Daejeon 35233, Republic of Korea
1 shared publication - Seung Young Chung
Department of Neurosurgery, Eulji University Hospital, College of Medicine, Eulji University, Daejeon, Korea
1 shared publication - Seungjun Ryu
Department of Neurosurgery, School of Medicine, Eulji University, Daejeon 34824, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 3 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4460
Long-Term Outcomes after Multimodal Treatment for Clival Chordoma: Efficacy of the Endonasal Transclival Approach with Early Adjuvant Radiation Therapy
This study investigates the long-term outcomes of clival chordoma patients treated with the endonasal transclival approach (ETCA) and early adjuvant radiation therapy. A retrospective review of 17 patients (2002–2013) showed a 10-year progression-free survival (PFS) rate of 67.4%, with the ETCA group showing fewer progressions and cranial neuropathies than those treated with combined approaches. The ETCA, a minimally invasive technique, provided a similar extent of resection compared to conventional skull-base approaches and enabled safe delivery of high-dose adjuvant radiotherapy. The findings suggest that ETCA is an effective treatment for centrally located clival chordomas.
- 3 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4460
Open AccessLong-Term Outcomes after Multimodal Treatment for Clival Chordoma: Efficacy of the Endonasal Transclival Approach with Early Adjuvant Radiation Therapy
This study investigates the long-term outcomes of clival chordoma patients treated with the endonasal transclival approach (ETCA) and early adjuvant radiation therapy. A retrospective review of 17 patients (2002–2013) showed a 10-year progression-free survival (PFS) rate of 67.4%, with the ETCA group showing fewer progressions and cranial neuropathies than those treated with combined approaches. The ETCA, a minimally invasive technique, provided a similar extent of resection compared to conventional skull-base approaches and enabled safe delivery of high-dose adjuvant radiotherapy. The findings suggest that ETCA is an effective treatment for centrally located clival chordomas.